non-muscle invasive bladder carcinoma
Role of first check cystoscopy in non-muscle invasive bladder carcinoma: A prospective and historical cohort study
... the muscle in the sample has been associated with increased residual disease resulting in ...the bladder prior to the procedure and then visualizing with an UV ...
123
Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma
... In the present study we used TMA instead of whole tis- sue section for immunohistochemical analysis. Gudjonsson et al. in their study analyzed COX-2 among different markers on TMA and they found that proteins assessed ...
8
Risk factor assessment in high-risk, bacillus Calmette–Guérin-treated, non-muscle-invasive bladder cancer
... lary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomized phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance ...
8
Proteomics research on muscle-invasive bladder transitional cell carcinoma
... of non-coding introns from precursor messenger ...the invasive, metastatic and adaptive prop- erties typical in most ...between muscle-invasive BTCC and normal ...
8
Bladder preservation approach versus radical cystectomy for high grade non muscle invasive bladder cancer: a meta analysis of cohort studies
... were non-muscle-invasive bladder cancer ...papillary carcinoma and carcin- oma in situ (CIS) which is flat and non-papillary) or lamina propria (T1) based on the American Joint ...
15
The management of BCG failure in non muscle invasive bladder cancer: an update
... with non-muscle-invasive bladder cancer (NMIBC) will fail intravesical bacillus Calmette-Guérin (BCG) ...T1 bladder cancer and/or carcinoma in situ (CIS or TIS) is more ...
7
Original Article Expression and function of SIRT6 in muscle invasive urothelial carcinoma of the bladder
... and non-bladder cancer lines support a role of SIRT6 in facilitating DNA double strand break repair, inhibiting SIRT6 expression in bladder cancer lines do not sensitize them to drug in- duced DNA ...
10
Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer
... urothelial carcinoma of the upper urinary tract or nonurothelial carcinoma histology were ...VBNI, carcinoma in situ (CIS) and lymphovascular involvement (LVI); and deter- mination of the growth ...
9
Prospective analysis of voided and barbotage urine cytology in the routine follow up of non-muscle invasive transitional cell carcinoma of bladder
... Cystoscopy continues to be the reference standard for the detection and follow-up of bladder cancer. However, its accuracy can be reduced in certain situations, including poor visualization caused by inflammatory ...
82
BOXIT-A Randomised Phase III Placebo-controlled Trial Evaluating the Addition of Celecoxib to Standard Treatment of Transitional Cell Carcinoma of the Bladder (CRUK/07/004).
... Celecoxib did not reduce the overall risk of recurrence in intermediate or high risk non-muscle invasive bladder cancer. Sub-group analysis report that time to recurrence [r] ...
30
<p>Collagen stiffness promoted non-muscle-invasive bladder cancer progression to muscle-invasive bladder cancer</p>
... cell carcinoma and act as one of the etiologically linked genes in aortic dissected ...in invasive breast cancer compared with ductal carcinoma in situ, indicating that COL5A2 is related to tumor ...
17
Clinical rationale and safety of restaging transurethral resection in indication stratified patients with high risk non muscle invasive bladder cancer
... concomitant carcinoma in situ (Cis), number of tumors, and presence of detrusor muscle in the ...lacking muscle, Tx (1) was defined as the presence of lamina propria invasion in a specimen without ...
6
Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature
... urothelial carcinoma were typical compared with past reports ...urothelial carcinoma in our case was more than 70% posi- tive for ...pT1 bladder tumors ...
5
Original Article MiR-20a in cell-free urine as a potential diagnostic biomarker for non-muscle invasive bladder cancer: a Chinese population-based study
... in BCa tissues and urine of BCa patients [30]. Ac- cordingly, we speculat- ed that urinary miR-20a might be mainly derived from BCa cells. Aberrant circulating miR-20a ex- pression has been also reported in other solid ...
8
Genomic characterization of high-risk non-muscle invasive bladder cancer
... high-risk non-muscle- invasive bladder cancer (HR-NMIBC) have not been ...to muscle- invasive or advanced ...without carcinoma in ...metastatic bladder cancer (BC) ...
9
Diagnostic accuracy of MRI in differentiating non-muscle invasive from muscle invasive bladder carcinoma taking histopathological staging as a standard
... of bladder diseases (Prasad, 2006). It is mainly used to stage known bladder cancer detect tumor recurrence, and evaluate for secondary invasion of bladder by gynecologic, prostatic or rectal ...cell ...
6
Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
... urothelial carcinoma without CIS; (4) presence of primary NMIBC; (5) distant metastasis was excluded before surgery; (6) received intravesical chemotherapy by epirubicin or pirarubicin postoperatively, the regimen ...
10
Preoperative neutrophil–lymphocyte ratio and fibrinogen level in patients distinguish between muscle-invasive bladder cancer and non-muscle-invasive bladder cancer
... Some limitations of the present study must be mentioned. First, the information involved in this study were obtained from 669 patients, and the study was conducted in a single center with a small sample; hence, the ...
6
A 68 year old Caucasian man presenting with urinary bladder lymphoepithelioma: a case report
... In summary, our experiences with our patient as outlined in this report underline the main problems associated with bladder LELC. First, differential diagnosis can be difficult. Therefore, in our opinion diagnosis ...
5
Clinical and patient-reported outcomes of SPARE - a randomised feasibility study of selective bladder preservation versus radical cystectomy.
... selective bladder preservation group (corresponding to a critical hazard ratio (HR) for non-inferiority of ...conclude non-inferiority (80% power, one-sided ...the bladder preservation ...
34